Please assess the completion status of the following clinical trial:

Trial Title: Dexamethasone-induced Hiccup in Chemotherapy Patients Treated by Methylprednisolone Rotation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* all solid cancer patients on chemotherapy~* age \>18 years~* received dexamethasone as an antiemetic~Exclusion Criteria:~* brain metastases~* hiccups before dexamethasone administration~* uncontrolled diabetes mellitus~* uncontrolled esophagitis or peptic ulcer

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Methylprednisolone (Type: EXPERIMENTAL): Dexamethasone was replaced with methylprednisolone as an antiemetic.
- Dexamethasone (Type: ACTIVE_COMPARATOR): Dexamethasone was re-administered in the cycle.

Based on this trial design, predict the completion outcome and termination type (if applicable).